David W. Mullins

Affiliations: 
Immunology and Microbiology Dartmouth College, Hanover, NH, United States 
Area:
Immunology
Google:
"David Mullins"

Parents

Sign in to add mentor
Klaus D. Elgert grad student 1993-1998 Virginia Tech
Victor H. Engelhard post-doc 1999-2003 UVA

Children

Sign in to add trainee
Eleanor Clancy-Thompson grad student 2015 Dartmouth
Molly Harris-Jenkins post-doc 2011-2015 Dartmouth
Kiah Sanders post-doc 2015-2016 Dartmouth

Collaborators

Sign in to add collaborator
Craig L. Slingluff, collaborator 2003- UVA
Constance E. Brinckerhoff collaborator 2011- Dartmouth (Chemistry Tree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Butler KL, Clancy-Thompson E, Mullins DW. (2017) CXCR3(+) monocytes/macrophages are required for establishment of pulmonary metastases. Scientific Reports. 7: 45593
Mauldin IS, Wages NA, Stowman AM, et al. (2016) Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases. Cancer Immunology, Immunotherapy : Cii
Mauldin IS, Wages NA, Stowman AM, et al. (2016) Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases. Cancer Immunology, Immunotherapy : Cii
Whipple CA, Boni A, Fisher JL, et al. (2016) The mitogen-activated protein kinase pathway plays a critical role in regulating immunological properties of BRAF mutant cutaneous melanoma cells. Melanoma Research
Varn FS, Andrews EH, Mullins DW, et al. (2016) Integrative analysis of breast cancer reveals prognostic haematopoietic activity and patient-specific immune response profiles. Nature Communications. 7: 10248
Clancy-Thompson E, Perekslis TJ, Croteau W, et al. (2015) Melanoma induces, and adenosine suppresses, CXCR3-cognate chemokine production and T cell infiltration of lungs bearing metastatic-like disease. Cancer Immunology Research
Jenkins MH, Croteau W, Mullins DW, et al. (2015) The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells. Matrix Biology : Journal of the International Society For Matrix Biology. 48: 66-77
Jenkins MH, Brinckerhoff CE, Mullins DW. (2015) CXCR3 signaling in BRAFWT melanoma increases IL-8 expression and tumorigenicity. Plos One. 10: e0121140
Steinberg SM, Zhang P, Malik BT, et al. (2014) BRAF inhibition alleviates immune suppression in murine autochthonous melanoma. Cancer Immunology Research. 2: 1044-50
Jenkins MH, Steinberg SM, Alexander MP, et al. (2014) Multiple murine BRaf(V600E) melanoma cell lines with sensitivity to PLX4032. Pigment Cell & Melanoma Research. 27: 495-501
See more...